All In MedTech

FDA Clearance Tracker · P200039-S013

Shockwave Intravascular System with the C2/C2+ Coronary IVL Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 24, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 24, 2024

Approved

Time to decision

260 days

Received Feb 7, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P200039-S013
Device name
Shockwave Intravascular System with the C2/C2+ Coronary IVL Catheter
Applicant location
Santa Clara, CA
Received
Feb 7, 2024
Decided
Oct 24, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P200039

Device type

Device class
Class III

Every decision under product code QMG

FDA's approval statement

As written in FDA's record.

a new Shockwave Medical catheter manufacturing site located at SWAV CR SRL Coyol Free Zone, Building B50.B., El Coyol, Alajuela, Costa Rica and a new Steris AST sterilization facility located at Coyol Free Zone, Building B16, Alajuela, Costa Rica.

Source documents

Other decisions for Shockwave Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.